ENGLISH
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
Reduction in environmental pollution and emissions as waste is reused
Material for insulation purposes
High durability
Easy to store and transport
Simple and low-cost technique
More than 14 communities and 128 families participated
1,725 eco-bricks were recollected
8,000 USD in vouchers for supermarkets were distributed to the families who participated – a huge relief in COVID times
110,350 m2 of waste was recycled
More than 110,350 m2 of constructions will be built
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
Rationalising the use of energy and natural resources and act on the processes in order to optimise and reduceconsumption.
Reducing the production of waste by increasing and promoting recycling and recovering material wheneverpossible.
Ensuring that materials and procedures used don’t present any risk to the health of workers and to the environment.
Making sure that the use of materials, resources and the incorporation of safe and innovative technologies promoteenvironmental protection and minimise the environmental impacts.
Coaching and engaging employees to perform in a conscious and responsible manner, for the importance ofeveryone in guaranteeing product safety and for improving environmental performance.
Implementing good practices in order to comply with applicable legislation and other requirements that will leadto the environmental preservation.
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
In accordance with California Act Assembly Bill 906 and ASTM D7611/D7611M - Standard Practice for Coding Plastic Manufactured Articles for Resin Identification. Products comply with the compositional requirements of the Food and Drug Administration (FDA) regulation and European Regulation 10/2011.
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
Reassure consumers & provide trust to end-users (B2C), increasing public interest in recyclability and recycled content
Demonstrate compliance with legislation (B2B) & verify claims via third-party assessments
Show transparency about recyclability and waste origin and source
Support corporate sustainability claims about recycled content and recyclability of plastics
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
Excellent chemical resistance
Good barrier properties
Exceptional clarity
High brightness
Design flexibility
Easy to process
Excellent decorative ability
Processing flexibility
Fast cycle times
High impact resistance
Heavy wall capacity
Ease of secondary operations
Free of BPA and additives
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
The UPM life cycle assessment was carried out in accordance with ISO 14040 and based on cradle-to-gate systemboundary. As the biorefinery is currently in the process of being built, the LCA will be gradually updated with primary data.The study has been critically reviewed by an independent third party according to ISO 14044.
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
About Circ
Circ is on a mission to power the clean closet with patented technology that recycles global fashion waste back into textiles, over and over again. Circ is protecting our planet by reducing the need and demand for petroleum, trees, and other materials harvested from nature to manufacture clothes. Circ is building a truly circular economy for the fashion
industry. Headquartered in Danville, Virginia, a former epicenter of textile production in the United States, Circ is an Earthshot Prize Finalist, a Certified B Corporation revitalizing the future of material technology and manufacturing, and has been named in Fast Company’s list of World’s Most Innovative Companies of 2024. To learn more about Circ, visit www.circ.earth.
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
101148221- LIFE23-ENV-ES-LIFE POLITEX
Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or CINEA. Neither the European Union nor the granting authority can be held responsible for them.
https://www.aitex.es/portfolio/life-politex-fibre-fibre-circularity-textil-secyor-through-novel-polyster-recycling-technologies/
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
About CARBIOS
CARBIOS is a biotech company developing and industrializing biological solutions to reinvent the life cycle of plastic and textiles. Inspired by nature, CARBIOS develops enzyme-based processes to break down plastic with a mission to avoid plastic and textile pollution, and accelerate the transition to a circular economy. Its two disruptive technologies for the biorecycling of PET and the biodegradation of PLA are reaching industrial and commercial scale. Its biorecycling demonstration plant has been operational since 2021 and a first industrial plant, in partnership with Indorama Ventures, is currently under construction. CARBIOS, founded in 2011 by Truffle Capital, has received scientific recognition, notably with the cover of Nature, and is supported by prestigious brands in the cosmetics, Food & Beverage and apparel industries to enhance their products’ recyclability and circularity. Nestlé Waters, PepsiCo and Suntory Beverage & Food Europe are members of a packaging consortium founded by CARBIOS and L’Oréal. On, Patagonia, PUMA, PVH Corp. and Salomon collaborate with CARBIOS in a textile consortium.
Visit www.carbios.com/en to find out more about biotechnology powering plastic and textile circularity.
For latest news and media assets, visit our newsroom: www.carbios.com/newsroom/en/
LinkedIn: CARBIOS / Instagram: insideCarbios
Information on CARBIOS shares:
ISIN Code FR0011648716
Ticker Code Euronext Growth: ALCRB
LEI: 969500M2RCIWO4NO5F08
CARBIOS is eligible for the PEA-PME, a government program allowing French residents investing in SMEs to benefit from income tax rebates.
About Us
Selenis is a supplier of high quality and innovative specialty polyester solutions for diverse applications. Their mission relies on employing their profound knowledge of polymers, formulations, and processing, in partnership with their clients to develop future-fit solutions and commit to create opportunities.
Selenis is a global business with production sites in Portugal, Italy and the USA. Their production facilities have batch and continuous SSP units, permitting the production of a wide range of polymers to meet highly technical markets. Their production configurations provides Selenis the flexibility to produce both amorphous and crystallised products.
Committed to playing a role in society’s collective response to the plastic waste challenge, Selenis creates partnerships across the value chain to create long term solutions. Highly focused on sustainability, Selenis centers their innovation in developing resins with up to 50% recycled content and solutions that are fully recyclable in the PET stream. Their progress in molecular recycling turns waste into the building blocks of their specialty resins, contributing to the fight against climate change.
Selenis and their sister company, Evertis, are members of the IMG group, an international business headquartered in Portugal with operations around the world. Our businesses have been pioneers in the polyester industry since 1959. To discover more, please visit our website at www.selenis.com
About Selcare
Selcare is a brand of Selenis, producer of specialty resins for a diverse range of medical applications.
Selenis is a member of the IMG Group, present in the polymers market since 1959. Selenis aspires to improve patient safety with solutions specifically developed for the medical value chain.
Our Selcare brand offers high performing medical grade plastics and a wide range of supporting services.
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
About Magnomer
Magnomer is a startup offering patented coatings technology to help transform normally detrimental to recycling shrink sleeves into recycling preferred design. Magnomer’s Magmark SS coatings add magnetization to shrink sleeves, allowing them to be pulled out and captured during the recycling process by existing magnets. Magmark coatings are transparent and food safe, and print on using just one additional print station at the label converter. No changes to branding or design are necessary and Magmark coatings, an alternative to wash off inks, can be used on PETG or CPET films. Magmark SS has received industry recognition from the Association of Plastic Recyclers (APR) based on commercial scale trials. It has also been pre-qualified by How2Recycle for use on PETG, and can be used in compliance with U.S. Plastics Pact guidelines.
Please visit our website www.magnomer.com
Follow Magnomer on LinkedIn
About Us
Selenis is a supplier of high quality and innovative specialty polyester solutions for diverse applications. Their mission relies on employing their profound knowledge of polymers, formulations, and processing, in partnership with their clients to develop future-fit solutions and commit to create opportunities.
Selenis is a global business with production sites in Portugal, Italy and the USA. Their production facilities have batch and continuous SSP units, permitting the production of a wide range of polymers to meet highly technical markets. Their production configurations provides Selenis the flexibility to produce both amorphous and crystallised products.
Committed to playing a role in society’s collective response to the plastic waste challenge, Selenis creates partnerships across the value chain to create long term solutions. Highly focused on sustainability, Selenis centers their innovation in developing resins with up to 50% recycled content and solutions that are fully recyclable in the PET stream. Their progress in molecular recycling turns waste into the building blocks of their specialty resins, contributing to the fight against climate change.
Selenis and their sister company, Evertis, are members of the IMG group, an international business headquartered in Portugal with operations around the world. Our businesses have been pioneers in the polyester industry since 1959. To discover more, please visit our website at www.selenis.com
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
About Us
Selenis is a supplier of high quality and innovative specialty polyester solutions for diverse applications. Their mission relies on employing their profound knowledge of polymers, formulations, and processing, in partnership with their clients to develop future-fit solutions and commit to create opportunities.
Selenis is a global business with production sites in Portugal, Italy and the USA. Their production facilities have batch and continuous SSP units, permitting the production of a wide range of polymers to meet highly technical markets. Their production configurations provides Selenis the flexibility to produce both amorphous and crystallised products.
Committed to playing a role in society’s collective response to the plastic waste challenge, Selenis creates partnerships across the value chain to create long term solutions. Highly focused on sustainability, Selenis centers their innovation in developing resins with up to 50% recycled content and solutions that are fully recyclable in the PET stream. Their progress in molecular recycling turns waste into the building blocks of their specialty resins, contributing to the fight against climate change.
Selenis and their sister company, Evertis, are members of the IMG group, an international business headquartered in Portugal with operations around the world. Our businesses have been pioneers in the polyester industry since 1959. To discover more, please visit our website at www.selenis.com
About Syre
Syre is a textile impact company on a mission to decarbonize and dewaste the textile industry through textile-to-textile recycling at hyperscale, starting with polyester. At unprecedented speed and scale, Syre aims at driving the green shift of the textile industry to a future where every textile fiber sees a new day. The company’s textile-to-textile recycling solution provides circular polyester with quality on par with virgin polyester, but with a superior sustainability performance. Founded in 2023, Syre is initiated by Vargas and H&M Group. For more information: www.syre.com
(UPM, Helsinki, 29.10.2024 at 14:00 EET) – Selenis, UPM and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. This bottle takes sustainability in pharma packaging to a whole new level. Given the high regulatory and performance requirements for pharma packaging may limit the use of new or recycled materials, this bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to take a real step forward in the sustainable transformation of the pharmaceutical sector.
The collaboration is driven by a shared vision to support the pharmaceutical industry’s move towards more sustainable packaging solutions, without compromising on product safety and performance. The new pharmaceutical bottles, containing UPM’s carbon negative1 BioMEG, are made from Selenis’ Selcare’s partial BioPET resins. They have recently been approved for use in accordance with European Pharmacopeia, Version 11.4, Monograph 3.1.15 and will be available worldwide at Bormioli Pharma from Q1 2025.
“Our pioneering collaboration demonstrates that renewable, wood-based biochemicals can deliver the same high quality as fossil-based virgin materials, with significant environmental benefits. Bormioli Pharma’s containers provide a relevant solution for a market with limited and strictly monitored options to accelerate the sustainable transformation. It also provides tangible proof that scalable solutions are present in the market today,” said Michael Duetsch, Vice President of Biochemicals at UPM.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency. The partial BioPET containing UPM’s BioMEG is made from sustainably sourced materials, offering a radically lower carbon footprint while meeting the same quality requirements as traditional fossil PET. It can be processed and recycled in the currently existing processes without any technical adaptations. UPM is building the world’s first industry scale biorefinery that converts woody biomass into high value biochemicals, with hardwood being sourced from sustainably managed beechwood forests in the regions around Leuna, Germany.
“Selenis is thrilled to help drive forward the sustainable transformation of the pharmaceutical packaging industry with UPM and Bormioli Pharma, creating the world’s first European pharma-approved partial wood-based BioPET bottle”, said Eduardo Santos, Head of Corporate Strategy for Selenis.
Bormioli’s adoption of Selenis’ partial BioPET for the bottles progresses its ambitious goal of achieving more sustainable pharma packaging options for the market. It also emphasizes the wider feasibility of using regional, plant-based resources to phase out fossil resources for packaging with demanding application requirements.
For more information on UPM BioPura™ bio monoethylene glycol (BioMEG) visit https://www.upmbiochemicals.com/glycols/
UPM
We deliver renewable and responsible solutions and innovate for a future beyond fossils across six business areas: UPM Fibres, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers and UPM Plywood. As the industry leader in responsibility, we are committed to the UN Business Ambition for 1.5°C and the science-based targets to mitigate climate change. We employ 16,600 people worldwide and our annual sales are approximately EUR 10.5 billion. Our shares are listed on Nasdaq Helsinki Ltd. UPM Biofore – Beyond fossils. www.upm.com
Follow UPM on X | LinkedIn | Facebook | YouTube | Instagram | #UPM #biofore #beyondfossils
About Us
Selenis is a supplier of high quality and innovative specialty polyester solutions for diverse applications. Their mission relies on employing their profound knowledge of polymers, formulations, and processing, in partnership with their clients to develop future-fit solutions and commit to create opportunities.
Selenis is a global business with production sites in Portugal, Italy and the USA. Their production facilities have batch and continuous SSP units, permitting the production of a wide range of polymers to meet highly technical markets. Their production configurations provides Selenis the flexibility to produce both amorphous and crystallised products.
Committed to playing a role in society’s collective response to the plastic waste challenge, Selenis creates partnerships across the value chain to create long term solutions. Highly focused on sustainability, Selenis centers their innovation in developing resins with up to 50% recycled content and solutions that are fully recyclable in the PET stream. Their progress in molecular recycling turns waste into the building blocks of their specialty resins, contributing to the fight against climate change.
Selenis and their sister company, Evertis, are members of the IMG group, an international business headquartered in Portugal with operations around the world. Our businesses have been pioneers in the polyester industry since 1959. To discover more, please visit our website at www.selenis.com
Bormioli Pharma
Bormioli is a leading manufacturer of glass and plastic packaging solutions, serving the pharmaceutical and biopharmaceutical markets with complete systems, including bottles, closures and accessories. Renowned for its innovation and quality, Bormioli Pharma provides sustainable and advanced packaging options to actively support the sustainable transition of the pharma industry.
